Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

In a new study published in journal Scientific Reports, scientists at NDORMS and Queen Mary University of London have identified reasons underpinning the failure of inflammation to resolve in disorders of musculoskeletal soft tissues such as tendons.

Tendinopathy is a common global disease burden, causing pain and disability. These injuries require prolonged convalescence and there are currently no effective treatments. In the study by Dakin et al. the authors investigated why tendon inflammation fails to resolve in some patients with chronic disease. They studied profiles of pro-inflammatory and inflammation resolving lipids in tendon stromal fibroblasts isolated from patients with tendinopathy and compared them with those derived from healthy donors. Cells from patients with tendinopathy displayed a pro-inflammatory profile and dysregulated resolution responses compared to cells isolated from healthy volunteers. Incubating tendon stromal cells in tissue protective pro-resolving compounds including the aspirin stable isoform 15-epi-LXA4 induced the production of other proresolving lipid mediators and moderated the pro-inflammatory phenotype of diseased tendon stromal cells.

 The investigators noted that the effects of 15-epi-LXA4 treatment were more profound in healthy compared to diseased tendon stromal cells. They identified that cells from tendinopathy patients displayed enhanced ability to convert proresolving mediators to metabolites that carry reduced biological actions. Diseased tendon tissues and cells highly expressed an enzyme (15-PGDH) implicated in the inactivation of tissue protective proresolving mediators. Inhibition of 15-PGDH significantly reduced the further conversion of proresolving mediators and moderated the inflammatory phenotype of diseased tendon cells. These findings suggest that chronic inflammation in musculoskeletal soft tissues may result from dysregulated resolution responses. The authors propose that a dual pronged approach, using pro-resolving mediators together with inhibitors to 15-PGDH represents a novel therapeutic strategy to reduce local tendon inflammation and promote tissue repair. 

Figure 1

Spectra identifying the further metabolites of pro-resolving mediators in tendon stromal cells isolated from healthy volunteers (HV) and patients with tendon disease (TD). Cells from tendinopathy patients displayed enhanced ability to convert tissue protective proresolving mediators to metabolites that carry reduced biological actions. Staining shows cells from patients with tendinopathy highly express 15-PGDH, implicated in the inactivation of proresolving mediators.

Spectra-identifying-the-further-metabolites-of-pro-resolving-mediators.png

read THE FULL STUDY on Scientific Report:

Increased 15-PGDH expression leads to dysregulated resolution responses in stromal cells from patients with chronic tendinopathy. Stephanie G Dakin, Lucy Ly, Romain A. Colas, Udo Oppermann, Kim Wheway, Bridget Watkins, Jesmond Dalli, Andrew J Carr.

 

 

 

Similar stories

Patient and public involvement in Rheumatology research – embracing the wave of change

On launching the new OPEN ARMS PPI group in Oxford, Dr. Laura Coates explored the patient and public involvement (PPI) models of three academic centres in the UK to show how it benefits researchers, clinicians, and patients alike.

Neutrophil molecular wiring revealed: transcriptional blueprint of short-lived cells

Researchers publish the first blueprint of transcriptional factors that control neutrophil-driven inflammation in Nature Immunology.

NDORMS joins research partnership to understand links between overlapping long-term conditions

The links between different long-term health conditions will be explored in new research funded with a £2.5million grant from the Medical Research Council.

NDORMS researchers awarded grant for study on the effects of COVID-19 vaccines on long COVID

A team of NDORMS researchers including Doctor Annika Jödicke and Doctor Victoria Strauss have been awarded NIHR funding to carry out a study into the effects of different COVID-19 vaccines on long COVID.

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Researchers show the role of cilia in cartilage health

New research shows that disrupting primary cilia in juvenile, adolescent and early adulthood in cartilage stops it maturing correctly, making it more prone to thinning and the potential for osteoarthritis (OA) in later life.